A clinical trial to study the effect of drug Aghil Kattai Chooranam in patients having white discharge

A clinical study on vellai noi(leucorrhoea) with the evaluation of siddha drug "aghil kattai chooranam"

Status

Recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2017/05/008576

Enrollment

Registered

2017-05-16

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Vellai noi(leucorrhoea)

Interventions

Intervention1: Aghil Kattai Chooranam: Aghil Kattai Chooranam 1 gram bd with butter for 48 days Control Intervention1: Nil: Nil

Eligibility

Inclusion criteria

Inclusion criteria: 1.Whitish/yellowish discharge 2.Foul smelling discharge 3.Pruritis vulva 4.Dysuria 5.Cervicitis 6.Low backache and Lower abdominal pain 7.Positive Candida, Streptococcal and Staphlococcal infected patients .

Exclusion criteria

Exclusion criteria: 1.Known case of Diabetes mellitus 2.Known case of Sexually transmitted disease (Syphilis, HIV, Gonorrhoea) 3.Known case of Non specific leucorrhoea (Douches, pessaries, tampons, trauma, drugs, chemicals) 4.Pregnancy and Lactation 5.Known case of Malignancy in Uterus & Ovary 6.Trichomonas vaginalis and Monilial infections

Design outcomes

Primary

Measure	Time frame
Outcome of the treatment is assessed by negative of pap smear/wet smear and reduction in clinical symptoms.Timepoint: 48 Days	—

Secondary

Measure	Time frame
NilTimepoint: Nil	—

Countries

India

Contacts

Public ContactDr K Kanakavalli

Govt.siddha medical college,chennai 106

dr.kkanakavalli@gmail.com

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026